![Joseph Scheeren](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Scheeren
Directeur/Bestuurslid bij
BARINTHUS BIOTHERAPEUTICS ADR
Profiel
Joseph C.
F.
Scheeren is an Independent Non-Executive Director at Barinthus Biotherapeutics Plc since 2021.
Dr. Scheeren is an Adjunct Professor at Peking University.
Dr. Scheeren is a Member of the National Academy of Sciences.
Dr. Scheeren is a Member of the Académie nationale de Pharmacie.
Dr. Scheeren was President & Chief Executive Officer at Critical Path Institute from 2019 to 2021.
Dr. Scheeren was Chairman at Drug Information Association.
Dr. Scheeren was Independent Director at Barinthus Biotherapeutics (UK) Ltd. in 2021.
Dr. Scheeren was Senior Vice President at Bayer AG in 2018.
Dr. Scheeren completed undergraduate, graduate, and doctorate degrees at the University of Leiden.
Actieve functies van Joseph Scheeren
| Bedrijven | Functie | Begin |
|---|---|---|
| BARINTHUS BIOTHERAPEUTICS ADR | Directeur/Bestuurslid | 31-03-2021 |
Peking University
 Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Académie nationale de Pharmacie | Corporate Officer/Principal | - |
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Corporate Officer/Principal | - |
Eerdere bekende functies van Joseph Scheeren
| Bedrijven | Functie | Einde |
|---|---|---|
Vaccitech (UK) Ltd.
 Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Directeur/Bestuurslid | 31-03-2021 |
Critical Path Institute
 Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Provides medical drug and product development review process | Algemeen Directeur | 01-03-2021 |
| BAYER AG | Corporate Officer/Principal | 01-12-2018 |
Drug Information Association
 Drug Information Association Miscellaneous Commercial ServicesCommercial Services Operates as non-profit multidisciplinary association for health and well-being | Voorzitter | - |
Opleiding van Joseph Scheeren
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
71
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Leiden
 University of Leiden Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Academy of Sciences
National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services Operates as a private, nongovernmental institution that advises on issues related to science and technology | Commercial Services |
Drug Information Association
Drug Information Association Miscellaneous Commercial ServicesCommercial Services Operates as non-profit multidisciplinary association for health and well-being | Commercial Services |
Critical Path Institute
Critical Path Institute Miscellaneous Commercial ServicesCommercial Services Provides medical drug and product development review process | Commercial Services |
Académie nationale de Pharmacie | |
Vaccitech (UK) Ltd.
Vaccitech (UK) Ltd. BiotechnologyHealth Technology Engages in research and experimental development on biotechnology | Health Technology |
Vaccitech Plc
 Vaccitech Plc Pharmaceuticals: MajorHealth Technology Discovers and develops immunotherapeutic products and vaccines for the treatment and prevention of infectious and cancer diseases | Health Technology |
